Live from the NIH registry
Studies recruiting near Albuquerque right now
Top 25 of 350 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Lovelace Medical Center-Saint Joseph Square — Albuquerque, New Mexico (1.5 mi)
· Sponsor: SWOG Cancer Research Network
MDMA for Co-occurring PTSD and OUD After Childbirth
Stress Disorders, Post-Traumatic, Opioid Use Disorder
Phase 2
Interventional 15 participants sought
University of New Mexico Health Sciences — Albuquerque, New Mexico (1.5 mi)
· Sponsor: University of New Mexico
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma
Phase 1
Interventional 65 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Sameek Roychowdhury
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: NRG Oncology
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Melanoma (Skin Cancer), Melanoma Stage IIIB-IV
Phase 2, Phase 3
Interventional 135 participants sought
University of New Mexico — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Linnaeus Therapeutics, Inc.
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
292 — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Corcept Therapeutics
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Phase 3
Interventional 1,123 participants sought
University of New Mexico Comprehensive Cancer Center ( Site 6046) — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Raymond G. Murphy VA — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2
Interventional 146 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
Convergence Insufficiency, Traumatic Brain Injury
N/A
Interventional 100 participants sought
New Mexico VA Health Care System — Albuquerque, New Mexico (1.5 mi)
· Sponsor: New Jersey Institute of Technology
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Albuquerque, New Mexico (1.5 mi)
· Sponsor: AstraZeneca
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of New Mexico — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Jaeb Center for Health Research
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
PARKINSON DISEASE (Disorder)
Phase 2
Interventional 80 participants sought
Vima Site #014 — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Vima Therapeutics
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: SWOG Cancer Research Network
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Metastatic Breast Cancer
Phase 3
Interventional 600 participants sought
Presbyterian Kaseman Hospital — Albuquerque, New Mexico (1.5 mi)
· Sponsor: LeonaBio
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Presbyterian Hospital — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Pfizer
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
AMI Cardiogenic Shock
N/A
Observational 350 participants sought
New Mexico Heart — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Abiomed Inc.
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Presbyterian Hospital — Albuquerque, New Mexico (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Albuquerque, New Mexico (1.5 mi)
· Sponsor: 89bio, Inc.
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Janssen Research & Development, LLC
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Breast Neoplasms, Carcinoma, Ductal, Breast
N/A
Interventional 725 participants sought
New Mexico Oncology & Hematology Consultants — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Natera, Inc.
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Healthy Adult Participants
N/A
Observational 15 participants sought
Decentralized / At-Home Participation (U.S.) — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Ecotera Health LLC
Follow-up Visit of High Risk Infants
Infant, Newborn, Infant, Low Birth Weight
N/A
Observational 68,000 participants sought
University of New Mexico — Albuquerque, New Mexico (1.5 mi)
· Sponsor: NICHD Neonatal Research Network
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Cancer, Cancer Risk
N/A
Observational 47,500 participants sought
University of New Mexico Comprehensive Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: New Mexico Cancer Research Alliance